TTX.AX ASX
Tetratherix Ltd.
1W: +4.0%
1M: -8.6%
3M: +0.0%
YTD: +70.2%
1Y: +60.9%
A$6.31 ($4.39)
-0.07 (-1.10%)
Weekly Expected Move ±8.0%
A$5
A$6
A$6
A$7
A$7
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market CapA$342.1M ($237.9M)
52W Range3.09-8.08
Volume4,039
Avg Volume24,335
Beta1.64
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWilliam Anthony Knox
Employees25
SectorHealthcare
IndustryBiotechnology
IPO Date2025-06-30
Websitetetratherix.com
Unit 29
Alexandria, NSW 2015
AU
Alexandria, NSW 2015
AU
+61 2 9209 4032
About Tetratherix Ltd.
Established in 2015 and headquartered in Alexandria, Australia, Tetratherix Ltd. operates in the biomaterials and regenerative medicine sectors across both domestic and international markets. The company develops and supplies products using its proprietary Tetramatrix platform technology, with a focus on applications including bone regeneration, tissue spacing, and advanced tissue healing.
Latest News
No recent news
Recent Insider Trades
No insider trades found